AbbVie
ABBV
ABBV
2,021 hedge funds and large institutions have $76.1B invested in AbbVie in 2019 Q2 according to their latest regulatory filings, with 125 funds opening new positions, 905 increasing their positions, 762 reducing their positions, and 112 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
2% less call options, than puts
Call options by funds: $1.41B | Put options by funds: $1.43B
8% less capital invested
Capital invested by funds: $82.8B → $76.1B (-$6.76B)
15% less funds holding in top 10
Funds holding in top 10: 61 → 52 (-9)
Holders
2,021
Holding in Top 10
52
Calls
$1.41B
Puts
$1.43B
Top Buyers
| 1 | +$1.06B | |
| 2 | +$713M | |
| 3 | +$244M | |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$232M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$183M |
Top Sellers
| 1 | -$2.86B | |
| 2 | -$770M | |
| 3 | -$475M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$293M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$160M |